EIKN Eikon Therapeutics, Inc. - Common Stock
EIKN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
EIKN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
EIKN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 3 25.0%
- Buy 7 58.3%
- Hold 1 8.3%
- Sell 0 0.0%
- Strong Sell 1 8.3%
12-Month Price Target
4 analysts · 2026-08-17Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-2.46 | $-1.78 | -0.68% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| EIKN | — | — | — | — | — | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 19
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $105M | |
| Short-term Investments | $231M | |
| Prepaid Expense | $13M | |
| Current Assets | $349M | |
| PP&E (Net) | $143M | |
| PP&E (Gross) | $186M | |
| Accum. Depreciation | $43M | |
| Other Non-current Assets | $4M | |
| Total Assets | $595M | |
| Accounts Payable | $681.0K | |
| Current Liabilities | $55M | |
| Capital Leases | $247M | |
| Other Non-current Liabilities | $10M | |
| Total Liabilities | $312M | |
| Common Stock | $0 | |
| Retained Earnings | $-921M | |
| Stockholders' Equity | $-879M | |
| Liabilities + Equity | $595M | |
| Shares Outstanding | 3,068,490 |
Income Statement 10
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| R&D Expense | $75M | $70M | |
| SG&A Expense | $18M | $17M | |
| Operating Expenses | $93M | $87M | |
| Operating Income | $-93M | $-87M | |
| Net Income | $-88M | $-83M | |
| EPS (Basic) | $-1.63 | $-2.46 | |
| EPS (Diluted) | $-1.63 | $-2.46 | |
| Shares (Basic) | 54,143,162 | 33,700,550 | |
| Shares (Diluted) | 54,143,162 | 33,700,550 | |
| EBITDA | $-93M | $-87M |
Balance Sheet 19
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $143M | $161M | |
| Short-term Investments | $389M | $351M | |
| Prepaid Expense | $15M | $17M | |
| Current Assets | $547M | $530M | |
| PP&E (Net) | $133M | $138M | |
| PP&E (Gross) | $186M | $186M | |
| Accum. Depreciation | $53M | $48M | |
| Other Non-current Assets | $539.0K | $556.0K | |
| Total Assets | $780M | $851M | |
| Accounts Payable | $7M | $6M | |
| Current Liabilities | $55M | $45M | |
| Capital Leases | $243M | $245M | |
| Other Non-current Liabilities | $15M | $10M | |
| Total Liabilities | $313M | $300M | |
| Common Stock | $5.0K | $5.0K | |
| Retained Earnings | $-1.09B | $-1.00B | |
| Stockholders' Equity | $466M | $551M | |
| Liabilities + Equity | $780M | $851M | |
| Shares Outstanding | 54,148,887 | 54,138,555 |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Stock-based Comp | $4M | $3M | |
| Restructuring | $0 | · | |
| Operating Cash Flow | $-65M | $-90M | |
| CapEx | $251.0K | $262.0K | |
| Investing Cash Flow | $46M | $-203M | |
| Stock Issued | $25.0K | $277.0K | |
| Net Stock Activity | · | $277.0K | |
| Financing Cash Flow | $25.0K | $349M | |
| Free Cash Flow | · | $-90M |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Operating Margin | -1854.2% | -1994.0% | |
| Net Margin | -1755.2% | -1894.0% | |
| EBITDA Margin | -1854.2% | -1994.0% | |
| ROA | -22.7% | -19.5% | |
| ROE | -37.9% | -30.1% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 9.9 | 11.8 | |
| Quick Ratio | 9.6 | 11.4 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Valuation (TTM) 5
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Market Cap | $707M | $573M | |
| P/B | 1.5 | 1.0 | |
| P / Tangible Book | 1.5 | 1.0 | |
| P / Cash Flow | · | -6.4 | |
| P / FCF | · | -6.4 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 76 filers · $233.9M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 40 | 11 | 13 | 8 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $47,171,874 | 3,614,703 | 20.17% | Shares |
| Foresite Capital Management IV, LLC | $25,365,050 | 1,943,682 | 10.85% | Shares |
| Merck & Co., Inc. | $21,749,991 | 1,666,666 | 9.30% | Shares |
| Foresite Capital Management V, LLC | $17,212,728 | 1,318,983 | 7.36% | Shares |
| Capital World Investors | $15,346,069 | 1,175,944 | 6.56% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,041,326 | 922,707 | 5.15% | Shares |
| EcoR1 Capital, LLC | $9,560,508 | 732,606 | 4.09% | Shares |
| BAKER BROS. ADVISORS LP | $7,249,993 | 555,555 | 3.10% | Shares |
| ALLIANCEBERNSTEIN L.P. | $6,791,175 | 641,888 | 2.90% | Shares |
| SOROS CAPITAL MANAGEMENT LLC | $6,324,969 | 484,672 | 2.70% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $6,222,182 | 476,617 | 2.66% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $4,946,263 | 379,024 | 2.11% | Shares |
| STATE STREET CORP | $4,620,914 | 354,093 | 1.98% | Shares |
| FRANKLIN RESOURCES INC | $4,567,500 | 350,000 | 1.95% | Shares |
| StepStone Group LP | $4,182,697 | 395,340 | 1.79% | Shares |
| General Catalyst Group Management, LLC | $3,983,291 | 305,233 | 1.70% | Shares |
| BlackRock, Inc. | $3,754,824 | 287,726 | 1.61% | Shares |
| UBS Group AG | $3,444,313 | 263,932 | 1.47% | Shares |
| Parkman Healthcare Partners LLC | $3,341,492 | 256,053 | 1.43% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,376,470 | 182,105 | 1.02% | Shares |
| Schonfeld Strategic Advisors LLC | $2,346,063 | 179,775 | 1.00% | Shares |
| Ensign Peak Advisors, Inc | $2,224,895 | 170,490 | 0.95% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,943,080 | 148,895 | 0.83% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,936,751 | 148,410 | 0.83% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $1,755,199 | 134,498 | 0.75% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,735,911 | 133,020 | 0.74% | Shares |
| Comprehensive Financial Management LLC | $1,517,402 | 116,276 | 0.65% | Shares |
| Burkehill Global Management, LP | $1,500,750 | 115,000 | 0.64% | Shares |
| Affinity Asset Advisors, LLC | $1,278,913 | 98,001 | 0.55% | Shares |
| TD Asset Management Inc | $744,816 | 57,074 | 0.32% | Shares |
| ALPS ADVISORS INC | $717,071 | 54,948 | 0.31% | Shares |
| TCG Crossover Management, LLC | $494,621 | 37,902 | 0.21% | Shares |
| POLEN CAPITAL MANAGEMENT LLC | $466,433 | 35,742 | 0.20% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $461,409 | 35,357 | 0.20% | Shares |
| ProShare Advisors LLC | $387,389 | 29,685 | 0.17% | Shares |
| Nuveen, LLC | $378,293 | 28,988 | 0.16% | Shares |
| XTX Topco Ltd | $358,288 | 27,455 | 0.15% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $349,701 | 26,797 | 0.15% | Shares |
| RHUMBLINE ADVISERS | $319,496 | 24,483 | 0.14% | Shares |
| Integrated Wealth Concepts LLC | $284,492 | 21,800 | 0.12% | Shares |
| WELLS FARGO & COMPANY/MN | $252,491 | 19,348 | 0.11% | Shares |
| CITIGROUP INC | $202,575 | 15,523 | 0.09% | Shares |
| BANK OF AMERICA CORP /DE/ | $199,626 | 15,297 | 0.09% | Shares |
| TUDOR INVESTMENT CORP ET AL | $195,750 | 15,000 | 0.08% | Shares |
| Bank of New York Mellon Corp | $189,434 | 14,516 | 0.08% | Shares |
| MetLife Investment Management, LLC | $179,503 | 13,755 | 0.08% | Shares |
| CITADEL ADVISORS LLC | $169,950 | 13,023 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $130,252 | 9,981 | 0.06% | Shares |
| Invesco Ltd. | $113,274 | 8,680 | 0.05% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $111,042 | 8,509 | 0.05% | Shares |
| Vanguard Global Advisers, LLC | $110,716 | 8,484 | 0.05% | Shares |
| Police & Firemen's Retirement System of New Jersey | $83,781 | 6,420 | 0.04% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $80,910 | 6,200 | 0.03% | Shares |
| STRS OHIO | $56,115 | 4,300 | 0.02% | Shares |
| Tower Research Capital LLC (TRC) | $47,437 | 3,635 | 0.02% | Shares |
| NORTHERN TRUST CORP | $44,474 | 3,408 | 0.02% | Shares |
| BARCLAYS PLC | $40,638 | 3,114 | 0.02% | Shares |
| MORGAN STANLEY | $32,403 | 2,483 | 0.01% | Shares |
| Legal & General Group Plc | $27,640 | 2,118 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $25,774 | 1,975 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $22,707 | 1,740 | 0.01% | Shares |
| T. Rowe Price Investment Management, Inc. | $20,819 | 1,595,274 | 0.01% | Shares |
| JPMORGAN CHASE & CO | $16,562 | 1,300 | 0.01% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $12,880 | 986,922 | 0.01% | Shares |
| IFP Advisors, Inc | $11,980 | 918 | 0.01% | Shares |
| ROYAL BANK OF CANADA | $10,000 | 784 | 0.00% | Shares |
| State of Wyoming | $7,164 | 549 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $6,981 | 535 | 0.00% | Shares |
| Allworth Financial LP | $6,525 | 500 | 0.00% | Shares |
| DEUTSCHE BANK AG\ | $3,837 | 294 | 0.00% | Shares |
| Sterling Capital Management LLC | $2,480 | 190 | 0.00% | Shares |
| Aspect Partners, LLC | $1,644 | 126 | 0.00% | Shares |
| Fortitude Family Office, LLC | $1,579 | 121 | 0.00% | Shares |
| Jump Financial, LLC | $900 | 69 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $52 | 4 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $26 | 2 | 0.00% | Shares |
Company insiders 8 insiders · 5 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Roger M Perlmutter | Chief Executive Officer and Director | March 2, 2026 A | 284,857 | 0 | 0 | $0 |
| Alfred Lloyd Bowie Jr. | Chief Financial Officer | March 2, 2026 A | — | 0 | 0 | $0 |
| Michael A Klobuchar | Chief Operating Officer | March 2, 2026 A | — | 0 | 0 | $0 |
| Benjamin Bruno Thorner | General Counsel and Chief Business Officer | March 2, 2026 A | — | 0 | 0 | $0 |
| Roy D. Baynes | Chief Medical Officer | March 2, 2026 A | — | 0 | 0 | $0 |
| Robert Luther Huffines | Director | March 2, 2026 A | — | 0 | 0 | $0 |
| Kenneth C Frazier | Director | March 2, 2026 A | 111,111 | 1 | 0 | $1,999,998 |
| Josh Wolfe | Director | Feb. 6, 2026 C | 2,294,653 | 2 | 0 | $4,999,968 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| The Column Group IV GP, LP, The Column Group IV, LP, The Column Group IV-A, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson | Feb. 12, 2026 | 11.60% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 14 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| TINY · ProShares Trust | 0.88% | 6,700 NS | May 31, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 99,752 NS | May 31, 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 15,556 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| IWN · iShares Trust | — | — | Aug. 17, 2026 | Daily |
| IWO · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| IWM · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| IWC · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | July 13, 2026 | Daily |